KANSAS CITY, Mo., Feb. 10, 2016 /PRNewswire/ — Intouch Solutions, a leading marketing agency serving the pharmaceutical industry, recently identified an industry-wide trend regarding the evolution of digital sales aids (DSAs), […]
Special Feature — Agenda 2016: Bigger, better, faster, more
ACA, Agenda Special Feature, Big Data, Biosimilars, Data, FDA, FDA/Regulatory, February 2016, Healthcare, Healthcare Communications Agencies, Issue Archives, Managed Care, Marketing & Advertising, Presidential Candidates, Price Controls, Price Hikes, Pricing, Social Media, Technology, WearablesOr, why 2016 might look a little different than 2015 for pharmaceutical marketers.
2015 U.S. trends in aggregate spend, disclosure, and transparency
Biotech, Centers for Medicare & Medicaid Services, Centers for Medicare and Medicaid Services (CMS), CMS, Europe, European Federation of Pharmaceutical Industries and Associations (EFPIA), February 2016, Healthcare Physicians, Issue Archives, Medical Devices, Physicians, Surveys, Trends, U.S. Sunshine LawWhat are key trends in the transparency compliance landscape? And, how are life sciences manufacturers tackling growing requirements
TOKYO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that it received a recommendation by an independent data monitoring committee (IDMC) that the J-ALEX Study, a phase III study targeting ALK […]
2016 Annual Report: Top 10 Pipelines
"Bad" LDL Cholesterol, Alzheimer's Diseases, Approvals, Big Pharma, Biologics License Application (BLA), Biosimilars, Biotech, Biotech/Biopharma, Biotechnology, Bispecific CD19-directed CD3 T cell engager (BiTE) antibodies, Blockbusters, Blood Cancers, Breakthrough Designation, Breakthrough Therapy, Breakthrough Therapy Designation, Breakthrough Therapy Designation, Cells, Chimeric Antigen Receptor T Cell Therapy (CART), Cholesterol, Chronic Lymphocytic Leukemia, Clinical Trials, Collaboration, Collaborations, Collaborations, Cystic Fibrosis, Deals, Diabetes, DNA, EGFR Inhibitors, Europe, European Commission, FDA, FDA/Regulatory, February 2016, Glucagon-Like Peptide-1 (GLP-1) Analogs, Immune Response, Immune System, Immune Systems, Immunotherapies, Influenza, Inhalers, Issue Archives, Mantle Cell Lymphoma (MCL), Monoclonal Antibodies, Multiple Myeloma, NDA, Neuroscience, New Drug Application (NDA), New Molecular Entities, Non-Small Cell Lung Cancer, Oncology, Pain, Parkinson's, Parkinson's Disease, Plaque Psoriasis, Potential Blockbusters, Psoriasis, R&D, Sales, SGLT2 Inhibitors, Special Reports, Specialty Therapy, Technology, TGF-Beta Inhibitors, The New England Journal of Medicine (NEJM), Therapeutics, Top 10 Pipelines, Transforming Growth Factor-beta (TGFb), Type 1 Diabetes, Type 2 Diabetes, Vaccines, Waldenstrom’s macroglobulinemiaThe pharma industry’s R&D concentration has been shifting towards specialty therapy areas as research and development returns decline for some leaders.
The HBA announced that its 2016 Woman of the Year is Jennifer Cook, head of pharma, region Europe for Roche.
Daggerwing Group Inc. announces a move of the company’s New York operations from 250 Greenwich Street to the heart of SoHo at 536 Broadway.
Special Feature — Sales-Force Effectiveness: The Sweet 16
Accountable Care Organizations (ACOs), Electronic Health Records, February 2016, Healthcare Physicians, Incentives, Integrated Delivery Networks (IDNs), Issue Archives, Marketing & Advertising, Patients, Physicians, Sales & Marketing, Sales Reps, Sales-Force Effectiveness, TrendsIndustry experts tell Med Ad News about 16 trends that they believe will affect sales-force strategies in the immediate future.
The Medical Advertising Hall of Fame honored C. Marshall Paul and Scott Cotherman as 2016 inductees; Ken Begasse Sr. was the Lifetime Achievement Award recipient.
The CHC’s mission is to promote and protect the benefit, for society and individual patient care, of the free flow of healthcare information.